Catalyst Wire Dossier Catalyst Wire Dossier

Nerandomilast

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Nerandomilast, covering 2025-10-14 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases [Phase 3]

See pricing